| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/01/2004 | WO2004037073A3 Inflammatory bowel disease and irritable bowel syndrome ibd-first chek diagnostic panel |
| 07/01/2004 | WO2004031721A3 Detection of biological threat agents |
| 07/01/2004 | WO2004028551A9 Novel agents that modulate eph receptor activity |
| 07/01/2004 | WO2004025265A3 Test strip and method for determining ldl cholesterol concentration from whole blood |
| 07/01/2004 | WO2004025261A3 Method and apparatus detecting and analyzing oil and gas compositions using dual sensors |
| 07/01/2004 | WO2004024881A3 LDLRs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/01/2004 | WO2004024098A3 Method for the treatment of nephritis using anti-pdgf-dd antibodies |
| 07/01/2004 | WO2004023125A3 Impedance spectroscopy based systems and methods |
| 07/01/2004 | WO2004023098A3 Method for detecting transferase enzymatic activity |
| 07/01/2004 | WO2004022701A3 Exponential amplification of nucleic acids using nicking agents |
| 07/01/2004 | WO2004018644A3 HETEROGENEOUS FOLDAMERS CONTAINING α, β, AND/OR Ϝ-AMINO ACIDS |
| 07/01/2004 | WO2004018512A3 Polymorphisms in the human genes for oct1 and their use in diagnostic and therapeutic applications |
| 07/01/2004 | WO2004015394A3 Cancer diagnostics and prognostics |
| 07/01/2004 | WO2004015389A3 Methods of identifying compouds that modulate igg mediated mast cell activation |
| 07/01/2004 | WO2004013601A3 A method to quantitatively analyze conjugated dienes in hydrocarbon feeds and products as an indicator of fouling potential |
| 07/01/2004 | WO2004013151A3 Campylobacter glycans and glycopeptides |
| 07/01/2004 | WO2004012855A3 Ethylene glycol monolayer protected nanoparticles |
| 07/01/2004 | WO2004010074B1 Biosensor arrays and methods |
| 07/01/2004 | WO2004007747A3 Assays for assembly of ebola virus nucleocapsids |
| 07/01/2004 | WO2004005323A3 Affinity small molecules for the epo receptor |
| 07/01/2004 | WO2004003511A3 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance |
| 07/01/2004 | WO2004003493A3 Methods and kits for determining energy expenditure in living organisms by metabolic water production |
| 07/01/2004 | WO2003106966A3 Miniature biological fuel cell that is operational under physiological conditions, and associated devices and methods |
| 07/01/2004 | WO2003106694A3 Rapid methods for assessing therapeutic activity using animals expressing constitutively active g protein-coupled receptors |
| 07/01/2004 | WO2003102211A3 Method of detecting dna variation in sequence data |
| 07/01/2004 | WO2003100435A3 Diagnostics and therapeutic use of neuromedin u receptor 2 (nmu2) |
| 07/01/2004 | WO2003099996A3 Detection of secreted polypeptides |
| 07/01/2004 | WO2003098212A3 Method of isolating an endotehelial cell and method of donor specific crossmatching |
| 07/01/2004 | WO2003097666A3 Use of gastrin releasing peptide (grp) and its receptor in cancer screening |
| 07/01/2004 | WO2003093785B1 Biochips with surfaces coated with polysaccharide based hydrogels |
| 07/01/2004 | WO2003093438A3 Human adipocyte cell populations and methods for identifying modulators of same |
| 07/01/2004 | WO2003092616A3 Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer |
| 07/01/2004 | WO2003087342A3 Reducing non-specific binding in immunoassays performed on polymeric solid phases |
| 07/01/2004 | WO2003081236B1 Method and device for predicting cardiovascular events |
| 07/01/2004 | WO2003080649A3 Induction of hepatocyte proliferation in vitro by inhibition of cell cycle inhibitors |
| 07/01/2004 | WO2003075745A3 Detection, diagnosis, and monitoring of a medical condition or disease with artificial olfactometry |
| 07/01/2004 | WO2003074992A3 Phosphorylated proteins and uses related thereto |
| 07/01/2004 | WO2003068942A3 Identification of peptides that facilitate uptake and cytoplasmic and/or nuclear transport of proteins, dna and viruses |
| 07/01/2004 | WO2003042240A3 Polypeptides of pseudomonas aeruginosa |
| 07/01/2004 | WO2003030719A9 Methods and kits for use in selecting approaches to treating cancer |
| 07/01/2004 | WO2003021265A8 Genetic construct intracellular monitoring system |
| 07/01/2004 | WO2003009814A3 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of prostate cancer |
| 07/01/2004 | WO2003003986A3 Parathyroid hormone antibodies and related methods |
| 07/01/2004 | WO2002099083A3 Gfats as modifiers of the p53 pathway and methods of use |
| 07/01/2004 | WO2002090931A3 Methods for determining the prognosis for cancer patients using tucan |
| 07/01/2004 | WO2002062834A3 Mixture of peptides originating from a nef protein and applications thereof |
| 07/01/2004 | US20040128708 Transgenic rodent encoding nucleotide sequences coding melanin concentrating hormone type 1 receptor for use in treatment of sleep and eating disorders |
| 07/01/2004 | US20040128707 Animal model for pancreatic disorder associated with signal transduction; obesity prevention |
| 07/01/2004 | US20040128080 Clustering biological data using mutual information |
| 07/01/2004 | US20040128079 Artificial intelligent system for protein superfamily classification |
| 07/01/2004 | US20040128077 For automated tracking of individual cells over time disposed in the same well of a multi-well plate based on each individual cell's area and coordinates as found in images of the well taken over time |
| 07/01/2004 | US20040127719 for production of scaffolds on beads |
| 07/01/2004 | US20040127696 Growth differentiation factor-7 |
| 07/01/2004 | US20040127686 Signal transduction regulator binding protein for identifying modulators for prevention and treatment of cardiomyopic hypertrophy, heart failure and diabetes; drug screening |
| 07/01/2004 | US20040127573 Methods for increasing bone density |
| 07/01/2004 | US20040127474 Contacting the cell with a ptc agonist in a sufficient amount to inhibit the altered growth state, wherein the ptc agonist is a organic molecule having a molecular weight less than about 750 amu for inhibiting an altered growth state of a cell |
| 07/01/2004 | US20040127445 methods for screening for compounds capable of modulating the effect of B2M activity such as inhibitors, antibodies, variants or mimetics |
| 07/01/2004 | US20040127438 polypeptide (or its encoding nucleic acid molecule from Mycobacterium tuberculosis or related prokaryotes in the treatment of cancer, allergic disorders or conditions of immunoactivation, particularly asthma |
| 07/01/2004 | US20040127424 Inhibitors of cruzipain and other cysteine proteases |
| 07/01/2004 | US20040127401 CA125 gene and its use for diagnostic and therapeutic interventions |
| 07/01/2004 | US20040127395 Use of histamine H4 receptor modulators for the treatment of allergy and asthma |
| 07/01/2004 | US20040126904 Multiplex flow assays preferably with magnetic particles as solid phase |
| 07/01/2004 | US20040126903 Dynamically formed rotors for lock-in amplifier detection |
| 07/01/2004 | US20040126902 Ferromagnet iron oxide carrier which is superior in dispersibility in aqueous solutions as well as collectability for use in DNA isolation |
| 07/01/2004 | US20040126901 Clamped value beads |
| 07/01/2004 | US20040126899 Nanoporous membrane immunosensor |
| 07/01/2004 | US20040126898 Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (ANCA) |
| 07/01/2004 | US20040126897 detect the presence of analytes by spectral changes (color changes visible to the naked eye or with a calorimeter) that occur as a result of the specific binding of the analytes to polydiacetylene assemblies |
| 07/01/2004 | US20040126896 Method for determining multimers of plasma proteins |
| 07/01/2004 | US20040126894 Bioactive chip mass spectrometry |
| 07/01/2004 | US20040126893 Using artificial neural networks to analyze bodily fluids and identify pathological changes or viral pathogens which are associated with spongiform encephalopathies and neurodegenerative diseases |
| 07/01/2004 | US20040126891 Method for assaying reactive oxidants in smoke |
| 07/01/2004 | US20040126875 Assay stick |
| 07/01/2004 | US20040126874 Apparatus which utilizes rotating cone to generate stress to analyze and observe interactions between blood cell components and materials that make up artificial hearts and blood vessels |
| 07/01/2004 | US20040126870 Ncc2705-the genome of a bifodobacterium |
| 07/01/2004 | US20040126866 Comprises nucleotide sequences coding cyclic nucleotide phosphodiesterases for treatment of cardiovascular, depressive and vascular disorders; cardiotonic agents; antidepressants; antihypertensives; antithrombotics |
| 07/01/2004 | US20040126863 Comprises amino acid sequences for use in identifying modulators for diagnosis and treatment of respiratory and diabetes-induced peripheral vascular diseases; mimetics |
| 07/01/2004 | US20040126862 Comprises nucleotide sequences coding protein of urogenital system for identifying moduators for treatment of cell proliferative and metastatic disorders |
| 07/01/2004 | US20040126856 Factor ixa: factor Vllla interaction and methods therefor |
| 07/01/2004 | US20040126841 Novel G-protein coupled receptor, HLTEX11 |
| 07/01/2004 | US20040126839 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/01/2004 | US20040126837 Pseudo-tissues and uses thereof |
| 07/01/2004 | US20040126835 Cell assays |
| 07/01/2004 | US20040126834 Using sphingosine kinase expression to diagnose cancer, muscular and/or cell proliferative disorders |
| 07/01/2004 | US20040126833 Test strip and method for determining concentration of creatinine in a body fluid |
| 07/01/2004 | US20040126831 Functionalization of immobilized proteins |
| 07/01/2004 | US20040126830 Test strip and method for determining LDL cholesterol concentration from whole blood |
| 07/01/2004 | US20040126829 Bioassay which utilizes functionally active and soluble human leukocyte antigen for detecting antibodies which interfere in optimal allogeneic transplantation of organs, tissue and bone marrow |
| 07/01/2004 | US20040126828 Methods of diagnosing and treating pre-eclampsia or eclampsia |
| 07/01/2004 | US20040126826 Device for determining the concentration of 11-dehydrothromboxane B2 in a urine sample which indicates aspirin resistance and increased risk for a heart attack or stroke; assay strip; immunoassay |
| 07/01/2004 | US20040126825 Using a compounds ability to decrease integrin activation as a diagnostic tool for the identification of antagonistic modulators of neovascularizaton; antitumor/antiproliferative agents |
| 07/01/2004 | US20040126823 Identifying oncogenic kinase modulators which ca n be used in the prevention and treatment inflammation an d cell proliferative disorders |
| 07/01/2004 | US20040126822 Using glutathione peroxidase concentration as diagnostic tool in detecting infection; monitoring and prognosing damage to vascular endothelial cells |
| 07/01/2004 | US20040126821 Measuring reaction products of non reducing sugars and amino acid groups and using them as tools to diagnose nervous system disorders |
| 07/01/2004 | US20040126820 Using nanoparticles to identify and/or sequence biomolecules; forensic analysis; medical diagnostics |
| 07/01/2004 | US20040126818 Detecting receptor oligomerization |
| 07/01/2004 | US20040126817 Identifying modulators of cell surface channel proteins; prevention and treatment of cell proliferative, skin and hearing disorders |
| 07/01/2004 | US20040126813 Providing relevant biological relationships prior to viewing; expediated computer sorting |
| 07/01/2004 | US20040126810 Peptide substrate identified by type bont/b botulinus toxin and use thereof for assaying and/or detecting said toxin or corresponding inhibitors |
| 07/01/2004 | US20040126808 Small cell lung cancer associated antigens and uses therefor |